Turn Biotechnologies vs NewLimit

Develops mRNA-based epigenetic reprogramming medicines for age-related conditions via its ERA platform, with an early focus on skin.

Epigenetic reprogramming biotech using transcription factors to restore youthful gene expression in aging cells, starting with the liver.